Belzutifan
NCT04924075
Merck · Phase 2 · Recruiting · Enrollment 355
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
Belzutifan
Merck · Phase 2 · Recruiting · Enrollment 355
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.